ANKRD11 pathogenic variants and 16q24.3 microdeletions share an altered DNA methylation signature in patients with KBG syndrome
Human Molecular Genetics · 2023
DOI: 10.1093/hmg/ddac289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Zain Awamleh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada. Hauptthemen laut MEDLINE: Abnormalities, Multiple, Repressor Proteins. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, Simons Foundation Autism Research Initiative, Ontario Brain Institute (Province of Ontario Neurodevelopmental Disorders (POND) network.
Abstract (Originalsprache)
Pathogenic variants in ANKRD11 or microdeletions at 16q24.3 are the cause of KBG syndrome (KBGS), a neurodevelopmental syndrome characterized by intellectual disability, dental and skeletal anomalies, and characteristic facies. The ANKRD11 gene encodes the ankyrin repeat-containing protein 11A transcriptional regulator, which is expressed in the brain and implicated in neural development. Syndromic conditions caused by pathogenic variants in epigenetic regulatory genes show unique patterns of DNA methylation (DNAm) in peripheral blood, termed DNAm signatures. Given ANKRD11’s role in chromatin modification, we tested whether pathogenic ANKRD11 variants underlying KBGS are associated with a DNAm signature. We profiled whole-blood DNAm in 21 individuals with ANKRD11 variants, 2 individuals with microdeletions at 16q24.3 and 28 typically developing individuals, using Illumina’s Infinium EPIC array. We identified 95 differentially methylated CpG sites that distinguished individuals with KBGS and pathogenic variants in ANKRD11 (n = 14) from typically developing controls (n = 28). This DNAm signature was then validated in an independent cohort of seven individuals with KBGS and pathogenic ANKRD11 variants. We generated a machine learning model from the KBGS DNAm signature and classified the DNAm profiles of four individuals with variants of uncertain significance (VUS) in ANKRD11. We identified an intermediate classification score for an inherited missense variant transmitted from a clinically unaffected mother to her affected child. In conclusion, we show that the DNAm profiles of two individuals with 16q24.3 microdeletions were indistinguishable from the DNAm profiles of individuals with pathogenic variants in ANKRD11, and we demonstrate the diagnostic utility of the new KBGS signature by classifying the DNAm profiles of individuals with VUS in ANKRD11.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
- Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
- Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
- Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada.
- Institute of Medical Sciences, University of Toronto, Toronto, ON M5S 1A8, Canada.
- Medical Genetics Unit, Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra, Portugal.
ORCID-Profile: Stephen Scherer, Rosanna Weksberg
Förderung
- CIHR
- Simons Foundation Autism Research Initiative
- Ontario Brain Institute (Province of Ontario Neurodevelopmental Disorders (POND) network
- Canadian Institutes of Health Research
Zitieren
APA
Awamleh, Z., Choufani, S., Cytrynbaum, C., Alkuraya, F. S., Scherer, S., Fernandes, S., Rosas, C., Louro, P., Dias, P., Neves, M. T., Sousa, S. B., & Weksberg, R. (2023). ANKRD11 pathogenic variants and 16q24.3 microdeletions share an altered DNA methylation signature in patients with KBG syndrome. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddac289
Vancouver
Awamleh Z, Choufani S, Cytrynbaum C, Alkuraya FS, Scherer S, Fernandes S, et al. ANKRD11 pathogenic variants and 16q24.3 microdeletions share an altered DNA methylation signature in patients with KBG syndrome. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddac289
BibTeX
@article{Awamleh2023,
author = {Awamleh, Zain and Choufani, Sanaa and Cytrynbaum, Cheryl and Alkuraya, Fowzan S and Scherer, Stephen and Fernandes, Sofia and Rosas, Catarina and Louro, Pedro and Dias, Patricia and Neves, Mariana Tomásio and Sousa, Sérgio B and Weksberg, Rosanna},
title = {ANKRD11 pathogenic variants and 16q24.3 microdeletions share an altered DNA methylation signature in patients with KBG syndrome},
journal = {Human Molecular Genetics},
year = {2023},
doi = {10.1093/hmg/ddac289}
}
EUVIMED